오하이오의 주요우울장애 임상 시험
주요우울장애 관련 연구 29개가 오하이오 내 여러 지역에서 참여자를 모집하고 있습니다.
오하이오의 도시
공식 연구 텍스트(영어)
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Patient Priority Clinical Sites LLC, Cincinnati
- The Ohio State University, Columbus
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06559306A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- University of Cincinnati, Cincinnati
피험자 모집 중3상
12세 ~ 17세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07227454Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Quest Therapeutics of Avon Lake, Avon Lake
- University of Cincinnati Medical Center, Cincinnati
- The Ohio State University, Columbus
피험자 모집 중3상
18세 ~ 65세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05850689Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Cincinnati
피험자 모집 중3상
18세 ~ 65세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Independence
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07105111A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Independence
- Seaport Investigator Site, North Canton
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Neuro-Behavioral Clinical Research, North Canton
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07284667A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Insight Clinical Trials, Independence
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Columbus
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- The Cleveland Clinic Foundation, Cleveland
- The Ohio State University, Columbus
피험자 모집 중
22세 ~ 70세 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT06423430A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Patient Priority Clinical Sites LLC, Cincinnati
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07573176Positive Processes and Transition to Health (PATH)
- Case Western Reserve University, Cleveland
피험자 모집 중
18세 ~ 65세 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT06093906NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Mason
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06911112A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Cleveland Clinic, Cleveland
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT07592689A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Neuro-Behavioral Clinical Research, North Canton
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Insight Clinical Trials LLC, Independence
피험자 모집 중2상
18세 ~ 64세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06547489Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains
- Lindner Center of Hope, Mason
피험자 모집 중1/2상
18세 ~ 60세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06795451A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Insight Clinical Trials LLC, Independence
피험자 모집 중2상
18세 ~ 64세 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT07115329Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Avon Lake
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Cincinnati
- Clinical Research Site, Cincinnati
피험자 모집 중3상
18세 ~ 65세 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT07484217A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety
- The Ohio State University Department of Psychiatry, Columbus
피험자 모집 중2상
21세 ~ 65세 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT06820723A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Quest Therapeutics of Avon /ID# 277550, Avon Lake
- OSU Psychiatry Department /ID# 277529, Columbus
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT07276997A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- The Ohio State University, Columbus
- Neuro Behavioral Clinical Research, Inc., North Canton
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 5. 11. 업데이트됨 · NCT06524830Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation
- Cincinnati Childrens Hospital Medical Center, Cincinnati
피험자 모집 중
14세 ~ 18세 · 모든 성별 · 2026. 2. 11. 업데이트됨 · NCT07217444Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #109, Beachwood
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Avon Lake
피험자 모집 중3상
18세 이상 · 모든 성별 · 2025. 10. 29. 업데이트됨 · NCT06786624Mechanisms of Rumination Change in Adolescent Depression
- Nationwide Children's Hospital, Columbus
- The Ohio State University, Columbus
피험자 모집 중
14세 ~ 17세 · 모든 성별 · 2025. 8. 11. 업데이트됨 · NCT03859297Study of ALTO-300 in MDD
- Site 202, Cincinnati
피험자 모집 중2상
18세 ~ 70세 · 모든 성별 · 2025. 7. 24. 업데이트됨 · NCT05922878A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Cincinnati
피험자 모집 중4상
18세 ~ 65세 · 모든 성별 · 2025. 1. 23. 업데이트됨 · NCT06223880ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.